AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33140989 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) during the procedure
Number of subjects: 30
Study 33140989 — intervention group
Group type: COMPARATOR
Intervention: Control group (no VR)
Number of subjects: 30
Study 34643781 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-based fractal dimension analysis
Number of subjects: 215
Study 34643781 — intervention group
Group type: COMPARATOR
Intervention: nCRT (neoadjuvant chemoradiation therapy)
Number of subjects: 215
Study 35717156 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Interpersonal Psychotherapy (IPT-G) delivered by community health workers (CHWs)
Number of subjects: 24
Study 35717156 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (wait-listed group)
Number of subjects: 24
Study 35255916 — intervention group
Group type: EXPERIMENTAL
Intervention: EMF exposure (mimicking mobile phone base stations) during provocation sessions
Number of subjects: 150
Study 35255916 — intervention group
Group type: COMPARATOR
Intervention: Sham sessions (no EMF exposure)
Number of subjects: 150
Study 35255916 — intervention group
Group type: COMPARATOR
Intervention: Perceived EMF exposure in control group
Number of subjects: 150
Study 35255916 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived EMF exposure in IEI‐EMF group
Number of subjects: 150
Study 32924315 — intervention group
Group type: EXPERIMENTAL
Intervention: Angong Niuhuang pill (ANP)
Number of subjects: 80
Study 32924315 — intervention group
Group type: COMPARATOR
Intervention: Routine postoperative nursing
Number of subjects: 80
Study 32571245 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics features extracted from preoperative contrast-enhanced chest CT
Number of subjects: 300
Study 32571245 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics signature based on preoperative CT
Number of subjects: 300
Study 35294283 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast Iterative Restarted Networks (FIRENETs)
Number of subjects: 0
Study 35294283 — intervention group
Group type: EXPERIMENTAL
Intervention: Deterministic training algorithm
Number of subjects: 0
Study 35294283 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized training algorithm
Number of subjects: 0
Study 35294283 — intervention group
Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study 33872070 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab (200 mg once every 3 weeks for up to 35 cycles)
Number of subjects: 305
Study 33872070 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (platinum-based)
Number of subjects: 305
Study 34991464 — intervention group
Group type: EXPERIMENTAL
Intervention: Innovative endoscopic oropharyngeal airway
Number of subjects: 360
Study 34991464 — intervention group
Group type: COMPARATOR
Intervention: Conventional mouthpiece
Number of subjects: 360
Study 32308204 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 1 mg once daily for 6 months
Number of subjects: 16
Study 32308204 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 35485344 — intervention group
Group type: EXPERIMENTAL
Intervention: HBsAg-positive individuals with HBV-DNA ≥2000 IU/mL
Number of subjects: 2052
Study 35485344 — intervention group
Group type: COMPARATOR
Intervention: HBsAg-negative individuals
Number of subjects: 2052
Study 35485344 — intervention group
Group type: EXPERIMENTAL
Intervention: HBsAg-positive individuals with HBV-DNA <2000 IU/mL
Number of subjects: 2052
Study 35485344 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall HIV-positive participants
Number of subjects: 2052
Study 36322562 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced Nicotine Content (RNC) research cigarettes (nicotine content reduced to 0.2 mg over 18 weeks)
Number of subjects: 188
Study 36322562 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced Nicotine Content (RNC) research cigarettes
Number of subjects: 188
Study 36322562 — intervention group
Group type: COMPARATOR
Intervention: Usual Nicotine Content (UNC) research cigarettes (11.6 mg nicotine/cigarette)
Number of subjects: 188
Study 33817812 — intervention group
Group type: EXPERIMENTAL
Intervention: Xenogenic collagen matrix (CMX)
Number of subjects: 125
Study 33817812 — intervention group
Group type: COMPARATOR
Intervention: Connective tissue graft (CTG)
Number of subjects: 125
Study 35346577 — intervention group
Group type: EXPERIMENTAL
Intervention: Entecavir capsule plus Fuzheng Huayu tablet
Number of subjects: 0
Study 35346577 — intervention group
Group type: COMPARATOR
Intervention: Entecavir capsule plus simulant of Fuzheng Huayu
Number of subjects: 0
Study 33129754 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer support and diabetes self-management education group (PSEG)
Number of subjects: 58
Study 33129754 — intervention group
Group type: COMPARATOR
Intervention: Conventional diabetes self-management education-only group
Number of subjects: 58
Study 32415124 — intervention group
Group type: EXPERIMENTAL
Intervention: Hierarchical phononic crystals
Number of subjects: 0
Study 32415124 — intervention group
Group type: COMPARATOR
Intervention: Conventional phononic crystals
Number of subjects: 0
Study 34171864 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferric derisomaltose 20 mg/kg
Number of subjects: 204
Study 34171864 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 204
Study 34028974 — intervention group
Group type: EXPERIMENTAL
Intervention: Socket shield technique
Number of subjects: 42
Study 34028974 — intervention group
Group type: COMPARATOR
Intervention: Xenograft
Number of subjects: 42
Study 34028974 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 42
Study 34270409 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidimensional treatment framework (n = 28)
Number of subjects: 60
Study 34270409 — intervention group
Group type: COMPARATOR
Intervention: Unrelated education (control group, n = 32)
Number of subjects: 60
Study 34413518 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity Facebook advertising campaign
Number of subjects: 6998
Study 32486890 — intervention group
Group type: EXPERIMENTAL
Intervention: Transoral endoscopic thyroidectomy vestibular approach (TOETVA)
Number of subjects: 101
Study 32486890 — intervention group
Group type: COMPARATOR
Intervention: Unilateral axillobreast approach (UABA)
Number of subjects: 101
Study 32611377 — intervention group
Group type: EXPERIMENTAL
Intervention: Ilomedin
Number of subjects: 236
Study 32611377 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 236
Study 35094079 — intervention group
Group type: EXPERIMENTAL
Intervention: DS injection (25 g/L maltose + 25 g/L sucrose + 7.5 g/L NaCl)
Number of subjects: 600
Study 35094079 — intervention group
Group type: EXPERIMENTAL
Intervention: Met injection (5 g/L Met + 7.5 g/L NaCl)
Number of subjects: 600
Study 35094079 — intervention group
Group type: EXPERIMENTAL
Intervention: DS plus Met injection (25 g/L maltose + 25 g/L sucrose + 5 g/L Met + 7.5 g/L NaCl)
Number of subjects: 600
Study 35094079 — intervention group
Group type: COMPARATOR
Intervention: Noninjection
Number of subjects: 600
Study 33593769 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin/piperaquine (DP) treatment
Number of subjects: 640
Study 35470534 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional physiotherapy + exergaming
Number of subjects: 60
Study 35470534 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy
Number of subjects: 60
Study 34187537 — intervention group
Group type: EXPERIMENTAL
Intervention: Decompressive craniectomy (DC)
Number of subjects: 120
Study 34187537 — intervention group
Group type: COMPARATOR
Intervention: Craniotomy
Number of subjects: 120
Study 35256315 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (patients diagnosed by intervention-trained clinicians)
Number of subjects: 56
Study 35256315 — intervention group
Group type: COMPARATOR
Intervention: Control group (patients diagnosed by non-intervention-trained clinicians)
Number of subjects: 56
Study 33472172 — intervention group
Group type: EXPERIMENTAL
Intervention: Anserine 500 mg per day
Number of subjects: 36
Study 33472172 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 33518626 — intervention group
Group type: EXPERIMENTAL
Intervention: KM-248 measles component (n = 172)
Number of subjects: 178
Study 33518626 — intervention group
Group type: COMPARATOR
Intervention: Control measles vaccine (n = 85)
Number of subjects: 178
Study 33518626 — intervention group
Group type: EXPERIMENTAL
Intervention: KM-248
Number of subjects: 178
Study 35671133 — intervention group
Group type: EXPERIMENTAL
Intervention: Divided Attention + Positive Memory Reframing (DA + PMR)
Number of subjects: 41
Study 35671133 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive Memory Reframing (PMR)
Number of subjects: 41
Study 35671133 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 41
Study 33781209 — intervention group
Group type: EXPERIMENTAL
Intervention: eptinezumab
Number of subjects: 2867
Study 33781209 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 2867
Study 32148226 — intervention group
Group type: EXPERIMENTAL
Intervention: AMV+IntelliCycle ventilation mode
Number of subjects: 80
Study 34821140 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry needling
Number of subjects: 61
Study 34821140 — intervention group
Group type: COMPARATOR
Intervention: Sham needling
Number of subjects: 61
Study 33773476 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentrated and targeted fact-based instructional intervention
Number of subjects: 8376
Study 33773476 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer instructional intervention with scientific concepts
Number of subjects: 8376
Study 33773476 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 8376
Study 35034502 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabozantinib plus atezolizumab
Number of subjects: 0
Study 35034502 — intervention group
Group type: COMPARATOR
Intervention: Second novel hormone therapy (NHT)
Number of subjects: 0
Study 32450928 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial-based cognitive therapy (TBCT)
Number of subjects: 95
Study 32450928 — intervention group
Group type: COMPARATOR
Intervention: Prolonged exposure (PE)
Number of subjects: 95
Study 36141585 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity, Nutrition, and Body Image Intervention (6 interactive sessions over 3 months)
Number of subjects: 138
Study 36141585 — intervention group
Group type: COMPARATOR
Intervention: Control Group (no intervention)
Number of subjects: 138
Study 33355792 — intervention group
Group type: EXPERIMENTAL
Intervention: WeChat group
Number of subjects: 80
Study 33355792 — intervention group
Group type: COMPARATOR
Intervention: Leaflet group
Number of subjects: 80
Study 35768985 — intervention group
Group type: EXPERIMENTAL
Intervention: ESPB + fentanyl based intravenous patient‐controlled analgesia (IV‐PCA)
Number of subjects: 58
Study 35768985 — intervention group
Group type: COMPARATOR
Intervention: Control group (fentanyl based IV‐PCA only)
Number of subjects: 58
Study 32558951 — intervention group
Group type: EXPERIMENTAL
Intervention: ACL reconstruction surgery
Number of subjects: 14
Study 36448621 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard BP lowering treatment
Number of subjects: 2348
Study 36448621 — intervention group
Group type: COMPARATOR
Intervention: Intensive BP lowering treatment
Number of subjects: 2348
Study 35989252 — intervention group
Group type: EXPERIMENTAL
Intervention: 500-mg MXR tablet manufactured by Merck Pharmaceuticals Manufacturing (Jiangsu) Co.
Number of subjects: 54
Study 35989252 — intervention group
Group type: COMPARATOR
Intervention: 500-mg MXR tablet manufactured by Merck KGaA
Number of subjects: 54
Study 35989252 — intervention group
Group type: EXPERIMENTAL
Intervention: Both products under fed condition
Number of subjects: 54
Study 35989252 — intervention group
Group type: EXPERIMENTAL
Intervention: Both products under fasted condition
Number of subjects: 54
Study 35989252 — intervention group
Group type: EXPERIMENTAL
Intervention: Both products
Number of subjects: 54
Study 34246202 — intervention group
Group type: EXPERIMENTAL
Intervention: Training in abdominal pain (AP)
Number of subjects: 285
Study 34246202 — intervention group
Group type: EXPERIMENTAL
Intervention: Training in loss of consciousness (LOC)
Number of subjects: 285
Study 34246202 — intervention group
Group type: COMPARATOR
Intervention: Training in either symptom (AP or LOC)
Number of subjects: 285
Study 35218559 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline (4 mg × day−1, n = 13)
Number of subjects: 21
Study 35218559 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 8)
Number of subjects: 21
Study 33983557 — intervention group
Group type: EXPERIMENTAL
Intervention: Configural frequency analysis (CFA)
Number of subjects: 0
Study 33983557 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard log-linear modeling
Number of subjects: 0
Study 32228710 — intervention group
Group type: EXPERIMENTAL
Intervention: Haploidentical donor transplantation (HIDT)
Number of subjects: 208
Study 32228710 — intervention group
Group type: COMPARATOR
Intervention: Matched sibling donor transplantation (MSDT)
Number of subjects: 208
Study 35882530 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuropsychiatric Inventory-Questionnaire (NPI-Q)
Number of subjects: 318
Study 33975366 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration (10 1-minute bouts with 30 s recovery)
Number of subjects: 10
Study 33975366 — intervention group
Group type: COMPARATOR
Intervention: Whole-body vibration with lower-body blood flow restriction (10 cycles of 110 mmHg inflation with 30 s deflation during recovery)
Number of subjects: 10
Study 32027205 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolance type lancet
Number of subjects: 100
Study 32027205 — intervention group
Group type: EXPERIMENTAL
Intervention: Medlance Plus type lancet
Number of subjects: 100
Study 32027205 — intervention group
Group type: EXPERIMENTAL
Intervention: Acti-Lance type lancet
Number of subjects: 100
Study 32027205 — intervention group
Group type: EXPERIMENTAL
Intervention: MediSafe Solo type lancet
Number of subjects: 100
Study 33930234 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to instrumental classical music 20 minutes before the procedure
Number of subjects: 80
Study 33930234 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to instrumental classical music during the procedure
Number of subjects: 80
Study 33930234 — intervention group
Group type: COMPARATOR
Intervention: Control group (no music before or during the procedure)
Number of subjects: 80
Study 33727898 — intervention group
Group type: EXPERIMENTAL
Intervention: Preconception healthcare knowledge
Number of subjects: 522
Study 33727898 — intervention group
Group type: EXPERIMENTAL
Intervention: Housewives
Number of subjects: 522
Study 33727898 — intervention group
Group type: EXPERIMENTAL
Intervention: Education level of at least college
Number of subjects: 522
Study 33727898 — intervention group
Group type: EXPERIMENTAL
Intervention: No history of neonatal death
Number of subjects: 522
Study 33727898 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of family planning methods
Number of subjects: 522
Study 32951715 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin 6 mg daily, 1 hour before bedtime for 12 weeks
Number of subjects: 45
Study 33220071 — intervention group
Group type: EXPERIMENTAL
Intervention: FAS/PFAS group
Number of subjects: 64
Study 33220071 — intervention group
Group type: COMPARATOR
Intervention: HE group
Number of subjects: 64
Study 33220071 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 64
Study 33137591 — intervention group
Group type: EXPERIMENTAL
Intervention: PragmaCom training program
Number of subjects: 0
Study 33137591 — intervention group
Group type: COMPARATOR
Intervention: Cognitive control group
Number of subjects: 0
Study 35120408 — intervention group
Group type: EXPERIMENTAL
Intervention: 38% silver diamine fluoride (SDF) applied semiannually (twice, at a 6-month interval)
Number of subjects: 98
Study 35120408 — intervention group
Group type: COMPARATOR
Intervention: Restorative treatment (RT)
Number of subjects: 98
Study 33690249 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback-guided pelvic floor muscle training (EMG-BF)
Number of subjects: 51
Study 33690249 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback-guided pelvic floor muscle training with extracorporeal magnetic innervation (EMG-BF+ExMI)
Number of subjects: 51
Study 33690249 — intervention group
Group type: COMPARATOR
Intervention: Control group (not applicable)
Number of subjects: 51
Study 35800160 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 64
Study 35800160 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 64
Study 32720198 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 60
Study 32720198 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 60
Study 32720198 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 33316579 — intervention group
Group type: EXPERIMENTAL
Intervention: generic inhibitory control training (ICT)
Number of subjects: 100
Study 33316579 — intervention group
Group type: EXPERIMENTAL
Intervention: food-specific inhibitory control training (ICT)
Number of subjects: 100
Study 33316579 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 100
Study 33272309 — intervention group
Group type: EXPERIMENTAL
Intervention: Propolis supplementation (300 mg Iranian green propolis extract) three times a day for 2 weeks
Number of subjects: 80
Study 33272309 — intervention group
Group type: COMPARATOR
Intervention: Placebo (300 mg microcrystalline cellulose) three times a day for 2 weeks
Number of subjects: 80
Study 36282537 — intervention group
Group type: EXPERIMENTAL
Intervention: risankizumab 150 mg
Number of subjects: 444
Study 36282537 — intervention group
Group type: COMPARATOR
Intervention: risankizumab 150 mg (after switching from placebo)
Number of subjects: 444
Study 35691250 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy with gonadotropin‐releasing hormone analogs (GnRHa)
Number of subjects: 330
Study 35691250 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 330
Study 34024594 — intervention group
Group type: EXPERIMENTAL
Intervention: Pooling three soil samples in Pinus and Quercus stands
Number of subjects: 60
Study 34024594 — intervention group
Group type: EXPERIMENTAL
Intervention: Pooling six soil samples in mixed stands
Number of subjects: 60
Study 34024594 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing sample pools in monospecific-stands
Number of subjects: 60
Study 34024594 — intervention group
Group type: EXPERIMENTAL
Intervention: Sample pool size in mixed-stands
Number of subjects: 60
Study 34024594 — intervention group
Group type: EXPERIMENTAL
Intervention: Three samples in Mediterranean pure stands
Number of subjects: 60
Study 34024594 — intervention group
Group type: EXPERIMENTAL
Intervention: Six samples in mixed stands
Number of subjects: 60
Study 34658306 — intervention group
Group type: EXPERIMENTAL
Intervention: Prospective data collection
Number of subjects: 73
Study 34658306 — intervention group
Group type: COMPARATOR
Intervention: Retrospective data collection
Number of subjects: 73
Study 32049319 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose Reduction (DR)
Number of subjects: 120
Study 32049319 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 120
Study 35404990 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured pharmacotherapy optimization intervention
Number of subjects: 0
Study 35404990 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study 32406658 — intervention group
Group type: EXPERIMENTAL
Intervention: Large group (8 mm antrostomy)
Number of subjects: 20
Study 32406658 — intervention group
Group type: EXPERIMENTAL
Intervention: Small group (4 mm antrostomy)
Number of subjects: 20
Study 35550002 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-surgical management (rehabilitation)
Number of subjects: 0
Study 35550002 — intervention group
Group type: COMPARATOR
Intervention: Surgical management (reconstruction)
Number of subjects: 0
Study 36411177 — intervention group
Group type: EXPERIMENTAL
Intervention: Goldfish intervention for three days
Number of subjects: 112
Study 32596815 — intervention group
Group type: EXPERIMENTAL
Intervention: Art activity groups (intervention)
Number of subjects: 33
Study 32596815 — intervention group
Group type: COMPARATOR
Intervention: Control group (no art activities)
Number of subjects: 33
Study 35426396 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Recovery Program (ERP+)
Number of subjects: 101
Study 35426396 — intervention group
Group type: COMPARATOR
Intervention: Control group (ERP-)
Number of subjects: 101
Study 34107509 — intervention group
Group type: EXPERIMENTAL
Intervention: Peristaltic pulse dynamic leg compressions (PPDC)
Number of subjects: 26
Study 34107509 — intervention group
Group type: EXPERIMENTAL
Intervention: Local heat therapy (HT)
Number of subjects: 26
Study 34107509 — intervention group
Group type: COMPARATOR
Intervention: Control thigh (no treatment)
Number of subjects: 26
Study 34107509 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments (PPDC and HT)
Number of subjects: 26
Study 32545150 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) using methylene blue mediated with diode laser as an adjunct to mechanical debridement (MD)
Number of subjects: 40
Study 32545150 — intervention group
Group type: COMPARATOR
Intervention: Mechanical debridement (MD) with thrice daily application of 500 mg amoxicillin and 400 mg metronidazole
Number of subjects: 40
Study 32545150 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Group A and Group B
Number of subjects: 40
Study 34613578 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous platelet-rich plasma (PRP) infusion
Number of subjects: 30
Study 34613578 — intervention group
Group type: COMPARATOR
Intervention: Saline control infusion
Number of subjects: 30
Study 32271718 — intervention group
Group type: EXPERIMENTAL
Intervention: Exebacase + antibiotics
Number of subjects: 121
Study 32271718 — intervention group
Group type: COMPARATOR
Intervention: Antibiotics alone
Number of subjects: 121
Study 32271718 — intervention group
Group type: EXPERIMENTAL
Intervention: Exebacase + antibiotics (MRSA subgroup)
Number of subjects: 121
Study 32271718 — intervention group
Group type: COMPARATOR
Intervention: Antibiotics alone (MRSA subgroup)
Number of subjects: 121